Mirzotamab (Anti-B7-H3 / CD276)

Mirzotamab (Anti-B7-H3 / CD276) is a human IgG1κ monoclonal antibody targeting CD276/B7-H3. Mirzotamab is used to produce Mirzotamab clezutoclax antibody drug conjugate (ADC). MW: 144.86 KD.

• Supplier: Selleck Chemicals
• Product #: A2935
• Sku #: A2935-1mg